share_log

科倫博泰生物-B:自願公告創新藥物注射用SKB518新藥臨床試驗申請獲國家藥品監督管理局批准

SKB BIO-B: VOLUNTARY ANNOUNCEMENTINVESTIGATIONAL NEW DRUG APPROVAL FOR INNOVATIVE DRUGSKB518 FOR INJECTION BY THE NATIONAL MEDICAL PRODUCTSADMINISTRATION

Hong Kong Stock Exchange ·  Jun 17 16:45

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.